[1] CUTLIP D E, WINDECKER S, MEHRAN R, et al. Clinical end points in coronary stent trials: a case for standardized definitions[J]. Circulation, 2007, 115(17): 2344-2351.
[2] ARMSTRONG E J, FELDMAN D N, WANG T Y, et al. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis[J]. JACC Cardiovasc Interv, 2012, 5(2): 131-140.
[3] 杜发旺. 冠状动脉支架内血栓形成患者的危险因素及预后[J]. 介入放射学杂志, 2016, 25(2): 160-162.
[4] SHAH R, ROGERS K C, AHMED A J, et al. Effect of postprimary percutaneous coronary intervention bivalirudin infusion on acute stentthrombosis: meta-analysis of randomized controlled trials[J]. JACC Cardiovasc Interv, 2016, 9(13): 1313-1320
[5] YAMAK D, PANSE P, PAVLICEK W, et al. Non-calcified coronary atherosclerotic plaque characterization by dual energy computed tomography[J]. IEEE J Biomed Health Inform, 2014, 18(3): 939-945.
[6] DUMSER T, BORSCH M, WONHAS C. Coronary artery disease in aircrew fatalities: morphology, risk factors, and possible predictors[J]. Aviat Space Environ Med, 2013, 2(10): 142-147.
[7] FIEDLER K A, NDREPEPA G, SCHULZ S, et al. Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention[J]. Euro Intervention, 2016, 11(11): e1275-1282.
[8] KINNAIRD T, YAZJI K, THORNHILL L, et al. Post-procedural bivalirudin infusion following primary PCI to reduce stent thrombosis[J]. J Interv Cardiol, 2016, 29(2): 129-136.
[9] 文亚红, 曾晓斌, 赵颖, 等. 冠状动脉支架内急性亚急性血栓形成的诊治体会[J]. 四川医学, 2011, 32(11): 1708-1710.
[10] 张鹤萍, 陈晖, 李虹伟, 等. 25例冠状动脉支架内血栓患者临床分析[J]. 中国医师杂志, 2011, 13(3): 346-348.
[11] 戴敬, 吕树铮, 宋现涛, 等. 支架内血栓形成原因研究进展[J]. 中国实用内科杂志, 2014, 34(2): 209-210.
